To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus

Clinical trial NCT05926414 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05926414
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2023-09-21
Primary completion: 2025-01-17
Enrollment: 15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.